EUSA Pharma To Pay $180K Over Inflated Medicare Claims

Law360, New York (March 23, 2012, 4:55 PM EDT) -- EUSA Pharma USA Inc. has agreed to pay $180,000 to resolve a former employee’s $10 million whistleblower suit accusing the pharmaceutical firm of advising doctors to submit inflated claims to Medicare for certain imaging scans, the U.S. Department of Justice said Friday.

Langhorne, Pa.-based EUSA allegedly violated the False Claims Act by telling doctors to submit extra claims for certain scans after the use of its radiopharmaceutical ProstaScint, a diagnostic scanning chemical used to detect prostate cancer, according to prosecutors, who noted that the Society of...
To view the full article, register now.